AG-881

vorasidenib · Servier

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AG-881, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of AG-120 and AG-881 in Subjects With Low Grade Glioma [Phase 1]